KROS

Keros Therapeutics, Inc.

CIK 0001664710 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations

$12.03

↑ 0.36 (3.08%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Options; Risks: Fundamentals

Key stats

Market Cap

$238.10M

P/E Ratio

-2.80

EPS

2.34

Dividend Yield

Not covered

52W Position

18%

Beta

1.10

Valuation multiples

Fwd P/E

48.78

PEG

Not covered

P/B

0.83

P/S

7.28

EV/Revenue

-1.33

ROE

-29.8%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 18%

$9.69$22.55

Latest Financials

2025-12-31 FY

Revenue

$243.86M

Net Income

$87.01M

Total Assets

$338.02M

Free Cash Flow

$105.95M

KROS

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

KROS

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news